The FDA has given the nod to Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride, Pfizer) extended-release capsules for oral use (CII) for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Pharmacist pleads guilty in NYC oxycodone scheme
In one of the largest opioid diversion schemes to be uncovered in New York, a former pharmacy owner and her husband have pled guilty to several charges related to a multimillion-dollar oxycodone distribution scheme. Pharmacist Lilian Jakacki, 50, in …
(RTTNews.com) – ANI Pharmaceuticals, Inc. ( ANIP ) announced Monday the commercial launch of Oxycodone HCl Capsules, 5mg. Trailing twelve-month sales for the product are $7.5 million according to IMS Health.
The company noted that it is the third Schedule II narcotic product to the company’s commercial portfolio and sixth new product introduction in the second quarter of 2016.
Oxycodone hydrochloride is an (more…)